NEAL KLEIMAN to Incidence
This is a "connection" page, showing publications NEAL KLEIMAN has written about Incidence.
Connection Strength
0.561
-
When Prevention is Truly Better than Cure: Contrast-Associated Acute Kidney Injury in Percutaneous Coronary Intervention. Methodist Debakey Cardiovasc J. 2022; 18(4):73-85.
Score: 0.105
-
Bleeding Edge Technology: Retroperitoneal Hemorrhage and Its Implications for Transradial Access. Circ Cardiovasc Interv. 2018 02; 11(2):e006320.
Score: 0.076
-
Neurological Events Following Transcatheter Aortic Valve Replacement and Their Predictors: A Report From the CoreValve Trials. Circ Cardiovasc Interv. 2016 09; 9(9).
Score: 0.069
-
Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J. 2010 Oct; 160(4):767-74.
Score: 0.046
-
Late arrhythmias in patients with new-onset persistent left bundle branch block after transcatheter aortic valve replacement using a balloon-expandable valve. Heart Rhythm. 2021 10; 18(10):1733-1740.
Score: 0.024
-
Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis. JAMA Cardiol. 2021 01 01; 6(1):50-57.
Score: 0.023
-
Late Electrocardiographic Changes in Patients With New-Onset Left Bundle Branch Block Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 03 01; 125(5):795-802.
Score: 0.022
-
Arrhythmic Burden as Determined by Ambulatory Continuous Cardiac Monitoring in Patients With New-Onset Persistent Left Bundle Branch Block Following Transcatheter Aortic Valve?Replacement: The MARE Study. JACC Cardiovasc Interv. 2018 08 13; 11(15):1495-1505.
Score: 0.020
-
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting: Trends in Utilization and Propensity-Matched Analysis of In-Hospital Outcomes. Circ Cardiovasc Interv. 2018 04; 11(4):e006179.
Score: 0.019
-
Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2018 04; 105(4):1129-1136.
Score: 0.019
-
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis. J Thorac Cardiovasc Surg. 2016 Apr; 151(4):1014-22, 1023.e1-3.
Score: 0.016
-
Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64.
Score: 0.015
-
Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Circ Cardiovasc Interv. 2014 Jun; 7(3):365-73.
Score: 0.015
-
Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ?? study. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1057-64.
Score: 0.014
-
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2013 Oct 03; 168(3):2510-7.
Score: 0.014
-
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction". Am Heart J. 2011 Jul; 162(1):89-97.
Score: 0.012
-
The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circ Cardiovasc Qual Outcomes. 2011 Mar; 4(2):211-9.
Score: 0.012
-
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv. 2010 Sep; 3(9):920-7.
Score: 0.011
-
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J. 2009 Apr; 157(4):651-7.
Score: 0.010
-
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med. 2008 Jan 14; 168(1):94-102.
Score: 0.010
-
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. J Thromb Thrombolysis. 2005 Feb; 19(1):11-9.
Score: 0.008